Novel combination of anticholinergic and beta mimetics for the treatment of respiratory diseases

Details for Australian Patent Application No. 2005210083 (hide)

Owner MEDA Pharma GmbH & Co. KG

Inventors Szelenyi, Istvan; Goede, Joachim; Maus, Joachim; Cnota, Peter Jurgen

Agent Spruson & Ferguson

Pub. Number AU-B-2005210083

PCT Pub. Number WO2005/074900

Priority 60/541,957 06.02.04 US

Filing date 24 January 2005

Wipo publication date 18 August 2005

Acceptance publication date 11 March 2010

International Classifications

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/401 (2006.01) - Proline

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

13 July 2006 PCT application entered the National Phase

  PCT publication WO2005/074900 Priority application(s): WO2005/074900

11 March 2010 Application Accepted

  Published as AU-B-2005210083

8 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005210084-Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases

2005210077-Thiazolylimidazole derivatives and their use as inhibitors of microsmal triglyce ride transfer protein